It has been found in mouse experiments that BCFAs increase glucose production in hepatocytes and activate the mTORC1/S6K1 signaling pathway to exacerbate diet-induced obesity and insulin resistance (Choi et al., 2021). Here, RPS6KB1 is linked to obesity disorder.